it is downregulated in patient samplesdecreased expression is correlated with advanced TNM stage, larger tumor size, lymphatic metastasislower expression is associated with poorer prognosisoverexpression of SFTA1P inhibits cell proliferation, migration, and invasiondownregulation of SFTA1P is associated with decreased TP53 expression. This evidence concerns the gene SFTA1P and neoplasm.